US Stock MarketDetailed Quotes

LCTX Lineage Cell Therapeutics

Watchlist
  • 1.040
  • -0.050-4.59%
Close May 14 16:00 ET
  • 1.060
  • +0.020+1.92%
Post 19:05 ET
196.35MMarket Cap-8000P/E (TTM)

Lineage Cell Therapeutics Key Stats

Lineage Cell Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

1.44M

-39.48%
EPS(YoY)

-0.04

-33.33%

Strong Buy

May 11, 2024

Lineage Cell Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.304M--
--2024/Q2-- / 786.000K--
May 9, 20242024/Q11.444M / 1.360M--
Mar 7, 20242023/Q42.118M / 2.844M--
Nov 9, 20232023/Q31.246M / 2.650M--
Aug 10, 20232023/Q23.225M / 2.189M--
May 11, 20232023/Q12.386M / 2.012M--
Mar 9, 20232022/Q41.915M / 2.540M--
Nov 10, 20222022/Q32.998M / 4.313M--
Aug 11, 20222022/Q24.553M / 4.947M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 1.304M--
--2024/Q2-- / 786.000K--
May 9, 20242024/Q11.444M / 1.360M--
Mar 7, 20242023/Q42.118M / 2.844M--
Nov 9, 20232023/Q31.246M / 2.650M--
Aug 10, 20232023/Q23.225M / 2.189M--
May 11, 20232023/Q12.386M / 2.012M--
Mar 9, 20232022/Q41.915M / 2.540M--
Nov 10, 20222022/Q32.998M / 4.313M--
Aug 11, 20222022/Q24.553M / 4.947M--

Unlock Free Earnings Estimates

Lineage Cell Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: May 11, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg